Cardiac contractility modulation in heart failure with reduced ejection fraction: critical review of evidence and application perspectives

G Ital Cardiol

26 October Oct 2021 one month ago
  • Tondo C

This critical review illustrates the pathophysiological aspects and available scientific evidence about cardiac contractility modulation therapy. A useful algorithm dealing with the essential decisional knots to consider for device implantation in patients with heart failure in NYHA class >II and ejection fraction ≤45% is presented. The present review paves the way for the development of an Italian registry aiming at analyzing the characteristics of implanted patients based on a multiparametric approach, including cardiac biomarkers, to identify clinical profiles and predictors of response to therapy.

Reference

[Cardiac contractility modulation in heart failure with reduced ejection fraction: critical review of evidence and application perspectives]. Biffi M, Aspromonte N, Bongiorni MG, Clemenza F, D'Onofrio A, De Ferrari GM, Giallauria F, Grimaldi M, Oliva F, Senni M, Tondo C, Zecchin M, Cappannoli L, Giannotti Santoro M, Ziacchi M, Porcari A, Sinagra G. G Ital Cardiol 2021 Sep;22(9):727-741

Go to PubMed